help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lima, M.
Right arrow Articles by Orfao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lima, M.
Right arrow Articles by Orfao, A.
(American Journal of Pathology. 2003;163:763-771.)
© 2003 American Society for Investigative Pathology

TCR{alpha}ß+/CD4+ Large Granular Lymphocytosis

A New Clonal T-Cell Lymphoproliferative Disorder

Margarida Lima*, Julia Almeida{dagger}{ddagger}, Maria dos Anjos Teixeira*, Maria del Carmen Alguero{dagger}, Ana Helena Santos*, Ana Balanzategui{ddagger}§, Maria Luís Queirós*, Paloma Bárcena{dagger}{ddagger}, Antonio Izarra§, Sónia Fonseca*, Clara Bueno{dagger}{ddagger}, Benvindo Justiça*, Marcos Gonzalez{ddagger}§, Jesús F. San Miguel{ddagger}§ and Alberto Orfao{dagger}{ddagger}

From the Serviço de Hematologia Clinica,* Unidade de Citometria, Hospital Geral de Santo Antonio, Porto, Portugal; the Servicio de Citometria,{dagger} Universidad de Salamanca, Salamanca, Spain; the Centro de Investigación del Cáncer,{ddagger} Salamanca, Spain; and the Servicio de Hematología,§ Hospital Universitario de Salamanca, Salamanca, Spain

Large granular lymphocyte (LGL) leukemia is a well-recognized disease of mature T-CD8+ or less frequently natural killer cells; in contrast, monoclonal expansions of CD4+ T-LGL have only been sporadically reported in the literature. In the present article we have explored throughout a period of 56 months the incidence of monoclonal expansions of CD4+ T-LGL in a population of 2.2 million inhabitants and analyzed the immunophenotype and the pattern of cytokine production of clonal CD4+ T cells of a series of 34 consecutive cases. Like CD8+ T-LGL leukemias, CD4+ T-LGL leukemia patients have an indolent disease; however, in contrast to CD8+ T-LGL leukemias, they do not show cytopenias and autoimmune phenomena and they frequently have associated neoplasias, which is usually determining the clinical course of the disease. Monoclonal CD4+ T-LGLshowed expression of TCR{alpha}ß, variable levels of CD8 (CD8-/+dim) and a homogeneous typical cytotoxic (granzyme B+, CD56+, CD57+, CD11b+/-) and activated/memory T cell (CD2+bright, CD7-/+dim, CD11a+bright, CD28-, CD62L- HLA-DR+) immunophenotype. In addition, they exhibited a Th1 pattern of cytokine production [interferon-{gamma}++, tumor necrosis factor-{alpha}++, interleukin (IL-2)-/+, IL-4-, IL-10-, IL-13-]. Phenotypic analysis of the TCR-Vß repertoire revealed large monoclonal TCR-Vß expansions; only a restricted number of TCR-Vß families were represented in the 34 cases analyzed. These findings suggest that monoclonal TCR{alpha}ß+/CD4+/NKa+/CD8-/+dim T-LGL represent a subgroup of monoclonal LGL lymphoproliferative disorders different from both CD8+ T-LGL and natural killer cell-type LGL leukemias. Longer follow-up periods are necessary to determine the exact significance of this clonal disorder.





This article has been cited by other articles:


Home page
BloodHome page
S. J. Richards
A "pathogenetic" role for CMV in CD4+ LGL proliferations
Blood, December 1, 2008; 112(12): 4367 - 4368.
[Full Text] [PDF]


Home page
BloodHome page
A. Rodriguez-Caballero, A. C. Garcia-Montero, P. Barcena, J. Almeida, F. Ruiz-Cabello, M. D. Tabernero, P. Garrido, S. Munoz-Criado, Y. Sandberg, A. W. Langerak, et al.
Expanded cells in monoclonal TCR-{alpha}{beta}+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens
Blood, December 1, 2008; 112(12): 4609 - 4616.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Garrido, F. Ruiz-Cabello, P. Barcena, Y. Sandberg, J. Canton, M. Lima, A. Balanzategui, M. Gonzalez, M. A. Lopez-Nevot, A. W. Langerak, et al.
Monoclonal TCR-V 13.1+/CD4+/NKa+/CD8 /+dim T-LGL lymphocytosis: evidence for an antigen-driven chronic T-cell stimulation origin
Blood, June 1, 2007; 109(11): 4890 - 4898.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Lima, J. Almeida, A. G. Montero, M. d. A. Teixeira, M. L. Queiros, A. H. Santos, A. Balanzategui, A. Estevinho, M. d. C. Alguero, P. Barcena, et al.
Clinicobiological, Immunophenotypic, and Molecular Characteristics of Monoclonal CD56-/+dim Chronic Natural Killer Cell Large Granular Lymphocytosis
Am. J. Pathol., October 1, 2004; 165(4): 1117 - 1127.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Herling, J. D. Khoury, L. T. Washington, M. Duvic, M. J. Keating, and D. Jones
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
Blood, July 15, 2004; 104(2): 328 - 335.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.